Completed
Efficacy and Safety of Once Daily Dosing Compared to Twice Daily Dosing of Nitisinone in HT-1
NCT02323529
- Conditions
- Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +10 more
- Locations
-
- Swedish Orphan Biovitrum Investigational Site Brussels, Belgium
- Swedish Orphan Biovitrum Investigational Site Copenhagen, Denmark
- Swedish Orphan Biovitrum Investigational Site Lyon, France
- Swedish Orphan Biovitrum Investigational Site Giessen, Germany